Filing Details

Accession Number:
0001562180-22-006102
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-15 20:34:41
Reporting Period:
2022-08-11
Accepted Time:
2022-08-15 20:34:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1603756 Axonics Inc. AXNX Surgical & Medical Instruments & Apparatus (3841) 454744083
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1756438 L. Danny Dearen 26 Technology Drive
Irvine CA 92618
See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-11 1,616 $1.32 22,270 No 4 M Direct
Common Stock Acquisiton 2022-08-11 2,044 $1.32 24,314 No 4 M Direct
Common Stock Acquisiton 2022-08-11 20,545 $1.63 44,859 No 4 M Direct
Common Stock Acquisiton 2022-08-11 7,047 $14.19 51,906 No 4 M Direct
Common Stock Acquisiton 2022-08-11 6,250 $25.82 58,156 No 4 M Direct
Common Stock Disposition 2022-08-11 26,760 $70.33 31,396 No 4 S Direct
Common Stock Disposition 2022-08-11 16,280 $71.26 15,116 No 4 S Direct
Common Stock Disposition 2022-08-11 6,960 $72.19 8,156 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to buy) Disposition 2022-08-11 1,616 $0.00 1,616 $1.32
Common Stock Stock Options (Right to buy) Disposition 2022-08-11 2,044 $0.00 2,044 $1.32
Common Stock Stock Options (Right to buy) Disposition 2022-08-11 20,545 $0.00 20,545 $1.63
Common Stock Stock Options (Right to buy) Disposition 2022-08-11 7,047 $0.00 7,047 $14.19
Common Stock Stock Options (Right to buy) Disposition 2022-08-11 6,250 $0.00 6,250 $25.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2027-05-22 No 4 M Direct
0 2027-07-05 No 4 M Direct
0 2028-03-30 No 4 M Direct
2,223 2029-01-30 No 4 M Direct
12,500 2029-12-12 No 4 M Direct
Footnotes
  1. The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  2. This transaction was executed in multiple trades at prices ranging from $69.96 to $70.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $70.96 to $71.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $71.98 to $72.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on July 5, 2017, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of July 5, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
  6. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on May 22, 2017, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of May 22, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
  7. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on March 30, 2018, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of March 30, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
  8. The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 1, 2023, provided the reporting person remains in continuous service on each vesting date.
  9. The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on December 12, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on December 1, 2023, provided the reporting person remains in continuous service on each vesting date.